NASDAQ:BBIO | Profit Breakdown | BridgeBio Pharma, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$243.68M-$107.08M-$155.89M-$155.89M
2026-03-31$194.52M-$105.96M-$166.56M
2025-12-31$154.18M-$139.56M-$194.76M-$194.64M
2025-09-30$120.7M-$145.2M-$186.48M-$184.94M
2025-06-30$110.57M-$134.28M-$181.66M-$183.76M
2025-03-31$116.63M-$104.37M-$169.61M
2024-12-31$5.88M-$226.03M-$266.24M-$267.39M
2024-09-30$2.73M-$191.75M-$164.25M-$164.25M
2024-06-30$2.17M-$175.54M-$75.54M-$75.54M
2024-03-31$211.12M$343,000.00-$36.16M
2023-12-31$1.75M-$177.42M-$170.33M
2023-09-30$4.09M-$157.69M-$179.49M
2023-06-30$1.64M-$146.1M-$160.7M
2023-03-31$1.83M-$126.16M-$142.73M
2022-12-31$1.87M-$129.23M-$140.57M
2022-09-30$338,000.00-$129.12M-$140.19M
2022-06-30$73.75M-$80.18M-$2.56M
2022-03-31$1.69M-$173.68M-$201.33M
2021-12-31$12.89M-$165.61M-$152.28M
2021-09-30$2.34M-$149.5M-$161.02M
2021-06-30$54.02M-$94.02M-$102.07M
2021-03-31$462,000.00-$167.5M-$171.08M
2020-12-31$122,000.00-$127.49M-$135.03M
2020-09-30$8.13M-$119.94M-$130.17M
2020-06-30-$124.57M-$136.21M
2020-03-31-$102.49M-$104.08M
2019-12-31$13.82M-$78.64M-$84.15M
2019-09-30$26.74M-$54.53M-$60.66M
2019-06-30-$69.32M-$74.33M
2019-03-31-$63.75M-$69.44M
2018-12-31-$65.58M-$49.24M
2018-09-30-$41.46M-$42.08M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$502.08M-$523.41M-$732.5M-$732.94M
2024-12-31$221.9M-$592.97M-$542.19M-$543.35M
2023-12-31$9.3M-$607.37M-$653.25M-$653.25M
2022-12-31$77.65M-$512.2M-$484.65M-$484.65M
2021-12-31$69.72M-$576.63M-$586.45M
2020-12-31$8.25M-$474.48M$505.49M-$505.49M
2019-12-31$40.56M-$266.24M$288.59M-$288.59M
2018-12-31-$183.66M$169.45M-$169.45M
2017-12-31-$43.86M$43.83M-$43.83M